
Dr Nihal Bandara
BDS (HONS), PhD (H.K.)
Expertise
Experienced microbiologist and a dentist, who is looking forward to discover, develop and validate novel molecular and microbiological methodologies for next generation diagnostic applications and instrumentation.
Current positions
Associate Professor in Molecular Microbiology
Bristol Dental School
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Biography
Currently, he serves as an Associate Professor in Molecular Microbiology at the University of Bristol. Alongside his research role, he holds key leadership positions as the Director of the International Foundation Programme for Dentistry and the International Director for the Bristol Dental School.
Research interests
As an experienced microbiologist and dentist, Dr. Bandara's research focuses on discovering, developing, and validating novel molecular and microbiological methodologies for next-generation diagnostic applications and instrumentation. Driven by the fact that microbial communal interactions in natural ecosystems remain largely unravelled, his core research aims to elucidate the physical and chemical interactions of microbes in competitive polymicrobial environments, specifically fungal-bacterial biofilm communities. By deeply understanding the physiology of the microbial communal lifestyle, his work seeks to define novel molecular pathways that can be targeted for translational research.
In particular, his work characterises how the human fungal pathogen Candida responds to various bacterial quorum sensing molecules (QSMs) using an inter-kingdom, fungal-bacterial interaction model system. Through these studies on polymicrobial biofilms and their internal fungal-bacterial interactions, Dr. Bandara aims to uncover how these complex relationships influence antimicrobial therapy and the development of antimicrobial resistance (AMR). By harnessing this information, his research seeks to design targeted therapies to disrupt and treat resilient polymicrobial biofilm infections. Furthermore, these ecological insights can be strategically translated to shift the eco-balance in favour of beneficial organisms across wider settings ranging from clinical interventions like managing device-associated and healthcare-associated infections, to industrial and environmental applications such as water purification, biofuel generation, and sustainable agriculture.
Projects and supervisions
Publications
Selected publications
10/06/2022Emerging strategies for environmental decontamination of the nosocomial fungal pathogen Candida auris
Journal of Medical Microbiology
Fluconazole resistance in Candida albicans is induced by Pseudomonas aeruginosa quorum sensing
Scientific Reports
A novel, quorum sensor-infused liposomal drug delivery system suppresses Candida albicans biofilms
International Journal of Pharmaceutics
Recent publications
18/06/2025Aggregation and biofilm formation of mono- and co-culture Candida species and Staphylococcus aureus are affected by nutrients in growth media
Biofouling
Antimicrobial Resistance Patterns and Biofilms Resurgence Ability of Escherichia coli Associated with Commercial Layer Chicken Farms in Sri Lanka
Veterinary Microbiology
Mono- and Co-Culture Biofilms of Candida auris or Candida albicans With Staphylococcus aureus Regulate Cell Viability and Pro-Inflammatory Cytokine Expression Differently in Oral Cancer Cell Lines
Journal of Oral Pathology and Medicine
Multidrug-Resistant Candida auris and its Role in Carcinogenesis
The Malaysian journal of medical sciences : MJMS
The diffusible signaling factor family in microbial signaling
Critical Reviews in Microbiology



